Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Operative External Beam Radiotherapy for Prostate Cancer: Randomized Trial Comparing Standard vs. Hypofractionated Radiation Therapy (PORT-HYFX)

NCT03987386 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03987386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03987386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Operative External Beam Radiotherapy for Prostate Cancer: Randomized Trial Comparing Standard vs. Hypofractionated Radiation Therapy (PORT-HYFX)
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 3
Overall status
Active, not recruiting
Start date
May 30, 2019
Completion date
November 1, 2027
Enrollment
186 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

stage i prostate cancer ajcc v8, stage ii prostate cancer ajcc v8, stage iii prostate cancer ajcc v8, stage iva prostate cancer ajcc v8